Samalin Investment Counsel, LLC Tekla Life Sciences Investors Transaction History
Samalin Investment Counsel, LLC
- $234 Million
- Q1 2025
A detailed history of Samalin Investment Counsel, LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Samalin Investment Counsel, LLC holds 20,416 shares of HQL stock, worth $252,137. This represents 0.11% of its overall portfolio holdings.
Number of Shares
20,416Holding current value
$252,137% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding HQL
# of Institutions
91Shares Held
9.06MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.19MShares$39.4 Million1.12% of portfolio
-
Penserra Capital Management LLC Orinda, CA747KShares$9.22 Million0.17% of portfolio
-
Morgan Stanley New York, NY519KShares$6.4 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY468KShares$5.78 Million0.25% of portfolio
-
Needham Investment Management LLC New York, NY379KShares$4.68 Million0.5% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...